Summary of clinicopathologic and molecular data of t(11;18)(q21;q21)-positive mucosa-associated lymphoid tissue lymphomas
Patients . | Age . | Sex . | Origin . | Lymphoma staging* . | BCL10 nuclear expression . | Breaking point‡ . | |
---|---|---|---|---|---|---|---|
API2 . | MALT1 . | ||||||
1 | 41 | M | Stomach | III (spleen, lymph node)† | + | 2048 | 715 |
2 | 49 | F | Stomach | IIE1 (lymph node) | NA | 2048 | 715 |
3 | 42 | F | Stomach | IIE1 (lymph node) | + | 2048 | 715 |
4 | 44 | M | Stomach | IIE1 | + | 2048 | 715 |
5 | 47 | M | Stomach | IIE | + | 2048 | 715 |
6 | 51 | M | Stomach | IE | + | 2048 | 715 |
7 | 54 | M | Stomach | IIE | NA | 2048 | 715 |
8 | 61 | M | Stomach | IIE2 | + | 2048 | 715 |
9 | 62 | M | Stomach | IE | + | 2048 | 715 |
10 | 65 | M | Stomach | IIE1 | + | 2048 | 715 |
11 | 72 | M | Stomach | III (spleen) | NA | 2048 | 715 |
12 | NA | M | Stomach | III | + | 2048 | 991 |
13 | 39 | M | Stomach | III (spleen, lymph node) | + | 2048 | 991 |
14 | 44 | M | Stomach | IV | + | 2048 | 991 |
15 | 49 | M | Stomach | IE | + | 2048 | 991 |
16 | 60 | F | Stomach | IV (small intestine, spleen, lymph node) | + | 2048 | 991 |
17 | 60 | M | Stomach | IE | + | 2048 | 991 |
18 | 44 | F | Stomach | IE | + | 2048 | 1018 |
19 | 63 | M | Stomach | III | + | 2048 | 1018 |
20 | 49 | M | Lung | NA | NA | 2048 | 715 |
21 | 66 | F | Lung | NA | + | 2048 | 715 |
22 | 49 | F | Lung | NA | + | 2048 | 715 |
23 | 46 | M | Lung | NA | NA | 2048 | 991 |
24 | 68 | M | Small intestine | IE | + | 2048 | 1018 |
25 | 53 | M | Salivary gland | NA | + | 2048 | 715 |
Patients . | Age . | Sex . | Origin . | Lymphoma staging* . | BCL10 nuclear expression . | Breaking point‡ . | |
---|---|---|---|---|---|---|---|
API2 . | MALT1 . | ||||||
1 | 41 | M | Stomach | III (spleen, lymph node)† | + | 2048 | 715 |
2 | 49 | F | Stomach | IIE1 (lymph node) | NA | 2048 | 715 |
3 | 42 | F | Stomach | IIE1 (lymph node) | + | 2048 | 715 |
4 | 44 | M | Stomach | IIE1 | + | 2048 | 715 |
5 | 47 | M | Stomach | IIE | + | 2048 | 715 |
6 | 51 | M | Stomach | IE | + | 2048 | 715 |
7 | 54 | M | Stomach | IIE | NA | 2048 | 715 |
8 | 61 | M | Stomach | IIE2 | + | 2048 | 715 |
9 | 62 | M | Stomach | IE | + | 2048 | 715 |
10 | 65 | M | Stomach | IIE1 | + | 2048 | 715 |
11 | 72 | M | Stomach | III (spleen) | NA | 2048 | 715 |
12 | NA | M | Stomach | III | + | 2048 | 991 |
13 | 39 | M | Stomach | III (spleen, lymph node) | + | 2048 | 991 |
14 | 44 | M | Stomach | IV | + | 2048 | 991 |
15 | 49 | M | Stomach | IE | + | 2048 | 991 |
16 | 60 | F | Stomach | IV (small intestine, spleen, lymph node) | + | 2048 | 991 |
17 | 60 | M | Stomach | IE | + | 2048 | 991 |
18 | 44 | F | Stomach | IE | + | 2048 | 1018 |
19 | 63 | M | Stomach | III | + | 2048 | 1018 |
20 | 49 | M | Lung | NA | NA | 2048 | 715 |
21 | 66 | F | Lung | NA | + | 2048 | 715 |
22 | 49 | F | Lung | NA | + | 2048 | 715 |
23 | 46 | M | Lung | NA | NA | 2048 | 991 |
24 | 68 | M | Small intestine | IE | + | 2048 | 1018 |
25 | 53 | M | Salivary gland | NA | + | 2048 | 715 |
Other abbreviations are explained in Table 1.
Patients 11 and 18 had a large cell component within the B-cell follicle.
NA, not applicable.
Ann Arbor-Musshoff staging system for extranodal lymphoma.
Tissues available for RT-PCR and showing fusion transcripts identical to their corresponding primary tumors are indicated in parentheses.